Metraipolis › archive › dc_86c464cb0440

Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials — Europe PMC PMID:42344814

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42344814
DOI
10.7759/cureus.109528
License (as archived)
solo-consultazione
Archived
2026-11-01T09:17:40.879Z
SHA-256 of the archived text
3a98265e002e56d8113e663c6547237086fb8c3c6b90003eef02cd1bc30b9b53
Stable URL of this page
https://metraipolis.com/documento/dc_86c464cb0440

How to cite

Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials — Europe PMC PMID:42344814 — Europe PMC (en), https://europepmc.org/article/MED/42344814 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_86c464cb0440 (Metraipolis archive dc_86c464cb0440, sha256 3a98265e002e56d8113e663c6547237086fb8c3c6b90003eef02cd1bc30b9b53)
BibTeX
@misc{dc86c464cb0440,
  title = {Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials — Europe PMC PMID:42344814},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42344814},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_86c464cb0440; sha256 3a98265e002e56d8113e663c6547237086fb8c3c6b90003eef02cd1bc30b9b53},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42344814. Agents can read the archived copy with the MCP tool read_document.